Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib

被引：0
|
作者：
Charles-Schoeman, Christina [1 ]
Valdez, Hernan [2 ]
Soma, Koshika [2 ]
Hwang, Lie-Ju [2 ]
DeMasi, Ryan [2 ]
Boy, Mary [3 ]
McInnes, Iain B. [4 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3024
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Surgery in Cancer Patients: Risk Factors for Major Adverse Cardiac Events
    Yang, Yong
    Wang, Hong-Zhi
    INDIAN JOURNAL OF SURGERY, 2020, 82 (06) : 1011 - 1015
  • [42] Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis
    Bissonnette, Robert
    Kerdel, Francisco
    Naldi, Luigi
    Papp, Kim
    Galindo, Claudia
    Langholff, Wayne
    Tang, K. L.
    Szapary, Philippe
    Fakharzadeh, Steven
    Srivastava, Bhaskar
    Goyal, Kavitha
    Gottlieb, Alice B.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (10) : 1002 - 1013
  • [43] The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia
    El-Solh, Ali A.
    Lawson, Yolanda
    Wilding, Gregory E.
    SLEEP HEALTH, 2023, 9 (05) : 717 - 725
  • [44] Polymorphisms in coagulation factors are not associated with risk of recurrent major adverse cardiovascular events in men
    van der Krabben, Marielke D.
    Doggen, Carine J. M.
    van der Bom, Johanneke G.
    Rosendaal, Frits R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E44 - E44
  • [45] Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
    Okkonen, Marjo
    Havulinna, Aki S.
    Ukkola, Olavi
    Huikuri, Heikki
    Pietila, Arto
    Koukkunen, Heli
    Lehto, Seppo
    Mustonen, Juha
    Ketonen, Matti
    Airaksinen, Juhani
    Kesaniemi, Y. Antero
    Salomaa, Veikko
    ANNALS OF MEDICINE, 2021, 53 (01) : 817 - 823
  • [46] Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies
    Chen, Dong-Yi
    Liu, Jia-Rou
    Tseng, Chi-Nan
    Hsieh, Ming-Jer
    Chuang, Cheng-Keng
    Pang, See-Tong
    Chen, Shao-Wei
    Hsieh, I-Chang
    Chu, Pao-Hsien
    Chen, Jen-Shi
    Chang, John Wen-Cheng
    Huang, Wen-Kuan
    See, Lai-Chu
    JACC: CARDIOONCOLOGY, 2022, 4 (02): : 223 - 234
  • [47] Independent effects of depression history and vitality in predicting major adverse cardiovascular and cerebrovascular events (MACCE) in patients with cardiovascular risk factors
    Herrmann-Lingen, C.
    Nolte, K.
    Binder, L.
    Edelmann, F.
    Wachter, R.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2020, 133
  • [48] Risk Factors for Gastrointestinal Adverse Events in HIV Treated and Untreated Patients
    Hill, Andrew
    Balkin, Andrew
    AIDS REVIEWS, 2009, 11 (01) : 30 - 38
  • [49] Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors A Randomized Clinical Trial
    Nissen, Steven E.
    Wolski, Kathy E.
    Prcela, Lisa
    Wadden, Thomas
    Buse, John B.
    Bakris, George
    Perez, Alfonso
    Smith, Steven R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (10): : 990 - 1004
  • [50] Teen Pregnancy and Risk of Premature Major Adverse Cardiovascular Events
    Agboola, Olayinka
    Satti, Danish Iltaf
    Mehta, Adhya
    Javed, Zulqarnain
    Epps, Kelly
    Honigberg, Michael
    Sarma, Amy
    Scott, Nandita
    Harrington, Colleen
    Saad, Antonio
    Spitz, Jared
    Sharma, Garima
    CIRCULATION, 2024, 150
12345